Patents
Patents for C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
07/2011
07/13/2011EP2343290A1 Diamine derivatives as factor X inhibitors
07/13/2011EP1463502B1 Broadspectrum heterocyclic substituted phenyl containing sulfonamide hiv protease inhibitors
07/13/2011CN102123987A Cycloalkylidene and heterocycloalkylidene histone deacetylase inhibitor compounds
07/12/2011US7977353 Heterocyclic aromatic compounds useful as growth hormone secretagogues
07/12/2011US7977333 Substituted pyridines and pyridazines with angiogenesis inhibiting activity
07/12/2011US7977329 Obesity therapy; using 3-benzoazepine compound
07/12/2011CA2577879C Substituted thienopyrrole carboxylic acid amides, pyrrolothiazole carboxylic acid amides, and related analogs as inhibitors of casein kinase i.epsilon.
07/07/2011WO2011081205A1 1,3,4-oxadiazole-2-carboxamide compound
07/07/2011WO2011080444A1 Novel (heterocycle/condensed piperidine)-(piperazinyl)-1-alcanone or (heterocycle/condensed pyrrolidine)-(piperazinyl)-1-alcanone derivatives, and use thereof as p75 inhibitors
07/07/2011US20110166164 THIAZOLO[5,4-d] PYRIMIDINES AND THEIR USE AS AGROCHEMICALS
07/07/2011US20110165183 Piperidine derivatives as jak3 inhibitors
07/07/2011CA2785679A1 1,3,4-oxadiazole-2-carboxamide compound
07/07/2011CA2784152A1 Novel (heterocycle/condensed piperidine)-(piperazinyl)-1-alcanone or (heterocycle/condensed pyrrolidine)-(piperazinyl)-1-alcanone derivatives, and use thereof as p75 inhibitors
07/06/2011CN101648962B C3/C3 fluoroquinolone dipolymer derivative taking s-triazolo-[3,4-b][1,3,4] thiadiazole as connecting chain and preparation method and application thereof
07/05/2011US7973050 5-[3-((R)(-)-5,7-Dibromo-1,2,3,4-tetrahydro-naphthalen-1-ylamino)-propylamino]-4H-thieno[3,2-b]pyridine-7-one; optically active; new target antibiotic, inhibitor of bacterial methionyl tRNA synthetase; antibiotic resistance; Clostridium difficile infection; mostly in immunodeficient, elderly
06/2011
06/30/2011WO2011076687A1 Pyridinone derivatives and pharmaceutical compositions thereof
06/30/2011WO2010132999A8 Methyl sulfanyl pyrmidmes useful as antiinflammatories, analgesics, and antiepileptics
06/30/2011US20110160208 Diaryl-substituted five-membered heterocycle derivative
06/30/2011US20110160207 Heterocyclic amide compounds useful as kinase inhibitors
06/30/2011US20110159563 Thyazolopyridin-2-yloxy-phenyl and thiazolopyrazin-2-yloxy-phenyl amines as modulators of leukotriene A4 hydrolase
06/29/2011EP2114937B1 Phenothiazin derivates, method for the production thereof and use thereof as pharmaceuticals
06/29/2011EP1730142B1 Novel ketoamides with cyclic p4's as inhibitors of ns3 serine protease of hepatitis c virus
06/29/2011CN102112473A Pyrrolidinyl-alkyl-amide derivatives, their preparation and their therapeutic application as ccr3 receptor ligands
06/29/2011CN101565428B Preparation method of prulifloxacin
06/28/2011US7968567 Compounds for the modulation of PPARγ activity
06/28/2011US7968562 an immune response modifier (IRM) compound 2-methyl-1-(2-methylpropyl)-1H-imidazo[4,5-c][1,5]naphthyridin-4-amine; fatty acids such as oleic acid, isostearic acid; hydrophobic, aprotic caprylic/capric triglyceride miscible with fatty acid; actinic keratosis, postsurgical scars, warts, atopic dermatitis
06/28/2011CA2602248C Dipeptidyl peptidase-iv inhibiting compounds, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent
06/28/2011CA2467672C Chemokine receptor antagonists and methods of use therefor
06/28/2011CA2427206C Sulfamides as gamma-secretase inhibitors
06/23/2011WO2011075615A1 5,5-fused arylene or heteroarylene hepatitis c virus inhibitors
06/23/2011WO2011075607A1 Novel inhibitors of hepatitis c virus replication
06/23/2011WO2011075525A1 Process for preparing cannabinoid receptor ligands
06/23/2011WO2011075522A1 Prodrug compounds useful as cannabinoid ligands
06/23/2011WO2011074560A1 Oxadiazole derivative having endothelial lipase inhibitory activity
06/23/2011WO2011073347A1 Bicyclic thiazoles as allosteric modulators of mglur5 receptors
06/23/2011WO2011073339A1 Bicyclic thiazoles as allosteric modulators of mglur5 receptors
06/23/2011WO2011073316A1 4-aryl-butane-1,3-diamides
06/23/2011WO2011073173A1 Improved method for producing intermediates for the production of macrocycles that are inhibitors of the proteasomic degradation of p27, such as argyrin and derivatives thereof
06/23/2011WO2011072779A1 Thiazole derivatives for treating diseases such as cancer
06/23/2011US20110152253 Spiroaminodihydrothiazine derivatives
06/23/2011US20110152251 Compounds for modulating tlr2
06/23/2011US20110152242 2,3-Substituted Fused Pyrimidin -4 (3H)-Ones as VR1 Antagonists
06/23/2011US20110150873 Anti-inflammatory compositions and combinations
06/23/2011US20110150827 5,5-fused arylene or heteroarylene hepatitis c virus inhibitors
06/23/2011CA2784748A1 5,5-fused arylene or heteroarylene hepatitis c virus inhibitors
06/23/2011CA2784710A1 Oxadiazole derivative having endothelial lipase inhibitory activity
06/23/2011CA2784067A1 Thiazole derivatives for the treatment of diseases such as cancer
06/23/2011CA2783938A1 Improved method for producing intermediates for the production of macrocycles that are inhibitors of the proteasomic degradation of p27, such as argyrin and derivatives thereof
06/23/2011CA2782950A1 Bicyclic thiazoles as allosteric modulators of mglur5 receptors
06/23/2011CA2782947A1 Bicyclic thiazoles as allosteric modulators of mglur5 receptors
06/22/2011EP2336136A1 Pyridine derivatives and their use in the treatment of psychotic disorders
06/22/2011EP2334301A1 Macrocyclics pyrimidines as aurora kinase inhibitors
06/22/2011EP2203448B1 Phenothiazine derivative having a double bond, method for the production thereof, and use thereof as a pharmaceutical
06/22/2011EP2054420B1 Benzimidazo[1,2-c][1,2,3]thiadiazol-7-sulfonamides as inhibitors of carbonic anhydrase and the intermediates for production thereof
06/22/2011CN102105475A Spiroaminodihydrothiazine derivatives
06/22/2011CN102105451A Glucokinase activators
06/22/2011CN102101867A Thiazinogeldanamycin and preparation method and use thereof
06/21/2011US7964722 Light-driven rotary molecular motors
06/21/2011US7964623 Tricyclic benzopyrane compound
06/21/2011US7964622 Indole acetic acid derivatives and their use as pharmaceutical agents
06/21/2011US7964361 Rigidized trimethine cyanine dyes
06/16/2011WO2011071136A1 Therapeutic agent for fibromyalgia
06/16/2011WO2011071109A1 Fused heterocyclic compound having amino group
06/16/2011WO2011070781A1 Substituted aminothiazine derivative
06/16/2011WO2011070177A2 Methods of facilitating neural cell survival using gdnf family ligand (gfl) mimetics or ret signaling pathway activators
06/16/2011US20110144343 Process for preparing cannabinoid receptor ligands
06/16/2011US20110144104 Pyrrolidinyl-alkyl-amide derivatives, their preparation, and their therapeutic application as ccr3 receptor ligands
06/16/2011US20110144084 6 substituted 2- heterocyclylamino pyrazine compounds as chk-1 inhibitors
06/16/2011US20110144068 3,4-diarylpyrazoles as protein kinase inhibitors
06/16/2011US20110143942 Pyrazolyl-Substituted Heterocycles and Their Use as Phytosanitary Products
06/16/2011US20110142796 Fused Pyridine, Pyrimidine and Triazine Compounds as Cell Cycle Inhibitors
06/16/2011DE102009058280A1 Thiazolderivate Thiazole derivatives
06/16/2011CA2783934A1 Methods of facilitating neural cell survival using gdnf family ligand (gfl) mimetics or ret signaling pathway activators
06/15/2011EP2332943A1 Novel fused aminodihydrothiazine derivative
06/15/2011EP2332912A1 Heteroarylaminosulfonylphenylderivates for use as sodium or calcium channel blockers in the treatment of pain
06/15/2011EP2331553A1 Hepatitis c virus inhibitors
06/15/2011CN1926129B Double amide insecticides
06/15/2011CN102093394A Lornoxicam tromethamine eutectic crystal
06/15/2011CN102093393A Method for preparing prulifloxacin and intermediate product thereof
06/15/2011CN101137661B Imidazothiazole derivative and method for producing same
06/15/2011CN101137660B Benzothiazole, thiazolopyridine, benzooxazole and oxazolopyridine derivatives as antidiabetic compounds
06/14/2011US7960568 Heterocyclyl-substituted sulfonamides for the treatment of cognitive or food ingestion related disorders
06/14/2011CA2494962C Tyrosine kinase inhibitors
06/09/2011WO2010147969A3 Gamma secretase modulators
06/09/2011US20110136782 Nitrogen-containing heterocyclic derivative and fungicide for agricultural and horticultural use
06/09/2011US20110135603 Inhibitors of phosphatidylinositol 3-kinase
06/09/2011US20110135594 Oxindolyl inhibitor compounds
06/09/2011CA2781891A1 Novel tricyclic compounds
06/09/2011CA2781010A1 Novel tricyclic compounds
06/08/2011EP2328903A1 Spiro-tetracyclic ring compounds as betasecretase modulators and methods of use
06/08/2011EP2328890A1 6 substituted 2-heterocyclylamino pyrazine compounds as chk-1 inhibitors
06/08/2011EP2328871A2 Hedgehog pathway modulators
06/08/2011EP1945648B1 Derivatives of 4,6-disubstituted 1,2,4-triazolo-1,3,4-thiadiazole, a process and uses thereof
06/08/2011EP1757610B1 Condensed pyrimidine derivative and xanthine oxidase inhibitor
06/08/2011CN102089314A Macrocyclic indole derivatives useful as hepatitis c virus inhibitors
06/08/2011CN102089291A Cyclopentylacrylic acid amide derivative
06/08/2011CN102089278A Compounds and compositions useful for the treatment of malaria
06/08/2011CN101619070B Preparation method of tenoxicam
06/08/2011CN101253181B Pyrido-thiazinium dyes
06/07/2011US7956193 Intramolecular C-H amination with sulfonyl azides
1 ... 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 ... 152